79 unchanged sentences
We compete primarily against other full-service CROs as well as services provided by in-house research and development (R&D) departments of biopharmaceutical companies.
−Removed: Our major CRO competitors include Laboratory Corporation of America Holdings, ICON plc, Syneos Health, Inc., PPD, Inc.
−Removed: (now part of Thermo Fisher Scientific Inc.), IQVIA Holdings Inc.
−Removed: and numerous specialty and regional CROs.
+Added: Our major CRO competitors include IQVIA Holdings Inc., ICON plc, PPD, Inc.
+Added: (now part of Thermo Fisher Scientific Inc.), Fortrea, Inc., and numerous specialty and regional CROs.
We generally compete on the basis of a number of factors, including experience within specific therapeutic areas, quality of staff and services, reliability, range of provided services, ability to recruit principal investigators and patients into studies expeditiously, ability to organize and manage large-scale, global clinical trials, global presence with strategically located facilities, speed to completion, price and overall value.
6 unchanged sentences
Our services are subject to varying regulatory requirements designed to ensure the quality and integrity of the pre-clinical and clinical trial process.
−Removed: In the United States, the FDA has primary authority to regulate these activities, in addition to the
−Removed: approval process, and the subsequent manufacturing, safety, labeling, storage, record keeping and marketing for these products, which are the responsibility of our customers.
+Added: In the United States, the FDA has primary authority to regulate these activities, in addition to the approval process, and the subsequent manufacturing, safety, labeling, storage, record keeping and marketing for these
+Added: products, which are the responsibility of our customers.
Before a marketing application for a drug is ready for submission to regulatory authorities, the candidate drug must often undergo rigorous testing in clinical trials.
74 unchanged sentences
based employees, approximately 21% are non-white, including 16% of management.
−Removed: None of our US employees are currently covered by a collective bargaining agreement specific to our Company.
+Added: None of our US employees are covered by a collective bargaining agreement specific to our Company.
Our commitment to compliance, people, safety, communities and the environment is further described in our 2023-2024 Corporate Responsibility Report published within the Investor Relations section of our website at investor.medpace.com.
40 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.